Artemisia judaica fractionation method
US6350478B1 · kind B1 · utility
0Cited by
1References
9Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Mar 27, 1997 |
| Grant date | Feb 26, 2002 |
| Priority date | — |
| Expiry date | Mar 27, 2017 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K36/282
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Extracts of herbs of the Artemisia family, some of which have been known in traditional medicine to have anti-diabetic effects, are fractionated chromatographically to remove unacceptable mutagenetic properties while retaining effectiveness against Diabetes mellitus. Certain fractions are found to be insulinomemetic while others have glucagon antagonistic properties. Mixtures of such fractions have optimum clinical effect.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.